Bahrain vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Sur
82.0%
in 2024
Bahrain rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Sur
How they compare
Bahrain currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Bahrain's figure about 1.2 times Sur's.
The two have swapped places 5 times across 12 shared years of data; in 2008 it was Sur ahead.
Bahrain ranks 1st and Sur ranks 2nd of 144 countries.
Sur has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 41.0% | 28.0% | Sur |
| 2010s | 66.2% | 72.0% | 5.8% | Sur |
| 2020s | 57.5% | 74.2% | 16.8% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Sur?
- Bahrain, at 100.0% against 82.0% in Sur as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Sur?
- 18.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Sur?
- 12 years are reported by both, from 2008 to 2023.
- How do Bahrain and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.